Zantac Cancer Lawsuit Lawyers
Zantac lawsuits claim the drug Zantac can be contaminated with the cancer-causing substance called N-nitrosodimethylamine (NDMA). Anyone who took Zantac and was later diagnosed with cancer should contact a lawyer for a free legal consultation regarding a potential Zantac cancer lawsuit.
Matthews & Associates is investigating cases for those who took Zantac and were later diagnosed with bladder or stomach cancer. Our firm is recognized as a national leader in prosecuting drug companies for dubious drugs. We are listed in Best Law Firms in America 2020. Our firm founder, David Matthews, is recognized as one of the Top 100 National Trial Lawyers.
What Is Zantac?
Zantac, or ranitidine, was once the world’s top-selling drug. It is available either by prescription or over the counter. In Sept. 2019, the FDA began investigating whether Zantac causes carcinogens to form in its users. It is suspected that Zantac causes levels of the probable carcinogen N-nitrosodimethylamine (NDMA) to rise when ingested by users.
We may file or settle a claim individually or as part of a group on a case-by-case basis.
Whether your claim is filed individually or as part of a group fighting the same defendant, our goal is always to provide each of our clients with individual attention.
FDA Discovers Carcinogen in Zantac
The U.S. FDA reported on September 13, 2019, that it had discovered the carcinogenic contaminant N-nitrosodimethylamine (NDMA) in Zantac (ranitidine). Zantac is a common heartburn medication available in both prescription and over-the-counter versions.
The FDA advisory stated that the level of contamination is “low”; however, the levels the agency called low have been found to be between 3,000 and 26,000 times higher than what the FDA had determined to be “safe.”
First Zantac Lawsuit
The first Zantac lawsuit was filed in California the same day FDA issued its advisory. Plaintiffs in Zantac lawsuits accuse drug makers Sanofi and Boerhringer Ingelheim of manufacturing, marketing, and selling a product they knew or should have known had been contaminated with an industrial chemical known to cause cancer.
Do I Have a Zantac Lawsuit?
If you took Zantac and have been diagnosed with bladder or stomach cancer, we will seek damages for you that include past and future:
- medical expenses
- pain and suffering
- physical and mental injuries
- wage loss
- loss of enjoyment of life
- punitive damages, if relevant
What Is NDMA?
NDMA is used in aviation for rocket fuel and industrial lubricants. NDMA is also a by-product of several industrial processes, including gasoline refining and wastewater treatment.
NDMA is also used to induce carcinogenesis in laboratory rats for cancer research. NDMA can also be found in several food products, such as cured meats. It’s also released in tobacco fumes. NDMA does not, however, appear to accumulate in tissues.
What Are the Symptoms of NDMA Contamination in a Person?
Besides causing cancer, NDMA is a potent hepatotoxin. Even short-term exposure to NDMA can cause liver damage, including liver fibrosis and scarring. Long-term exposure can also increase the risk of liver tumors, kidney tumors, and lung tumors.
NDMA overexposure symptoms include headache, fever, nausea, jaundice, vomiting, abdominal cramps, enlarged liver, reduced function of the liver, kidneys, and lungs, and dizziness.
Investigating the Cause of NDMA Contamination
The exact cause of the NDMA contamination is still under investigation. Nevertheless, during the period in which Boerhinger Ingelheim and Sanofi manufactured and marketed Zantac, scientific research demonstrated a clear link between ranitidine – the active ingredient listed in Zantac – and NDMA. The research showed that when ranitidine comes into contact with water, the resultant chemical reaction creates NDMA.
Despite knowing this cancer cocktail was formed, the drug makers chose to hide that fact from the government and consumers.
NDMA Is Extremely Hazardous
NDMA is classified as “extremely hazardous” under the federal Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA). Stringent reporting requirements, therefore, are supposed to guide companies and individuals who produce, store, or use NDMA in large quantities.
“Very informative and professional.”- Lydia C.
Very informative and professional. Answer thoroughly all my questions and concerns.
“Very professional from the beginning”- Jeffrey E.
Very professional from the beginning. always answered questions and had amazing follow through on insuring data submitted was accurate
“I am impressed that the Firm is always available and answers questions promptly”- Kweli Y.
I've been working with Matthews and Associates for 2 years. I am impressed that the Firm is always available and answers questions promptly. I am very satisfied with the services they provide and would recommend them.
“Matthews and Associates are very informative. Kept me up to date on what was happening with my case.”- Ron S.
Matthews and Associates are very informative. Kept me up to date on what was happening with my case. They were always polite when they were talking to me. Very professional and polite.
“I Love these guys!!!! They are SO Helpful, Kind, Knowledgeable,”I Love these guys!!!! They are SO Helpful, Kind, Knowledgeable, Smart, good with people, answer ALL ur questions, if they don't know the answer, it sure doesn't take them long to get you the answer!!!!!!!!!! I wouldn't want anyone else to handle my suit. They are AWESOME!!!!!!!!!- Genie S.
“They treat you with respect. They support you when needed.”- Sorangel T.
Matthews and Associates is one of a kind. They treat you with respect. They support you when needed. Plus they have locations in Texas and California with wonderful customer service. Billingual service always available.
Research from Valisure, an online pharmacy, along with that of Stanford University and others, found that NDMA resulted from the “inherent instability” of the ranitidine molecule. This means that all manufacturers, brand or generic, as well as all lots of ranitidine-containing medications, are affected and could generate very high levels of NDMA in the human body.
Zantac cancer link studies include:
- A 2004 National Cancer Institute study linked Ranitidine (Zantac) to Bladder Cancer.
- A 2016 Stanford University study gave 10 healthy volunteers 150 milligrams of Zantac and found that subsequent NDMA levels in their urine exceeded 47,000 nanograms.
- A 2017 study shows why urination of ranitidine into wastewater is suspected as a source of NDMA in municipal drinking water.